← Eichor
Study identifier: NCT05181891 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Condition: Alcohol Use Disorder (AUD) · Nicotine Use Disorder  ·  Sponsor: Washington State University

PhasePhase 2
Planned participants205
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among treatment-seeking smokers with an alcohol use disorder (AUD) who have initiated pharmacotherapy (varenicline; VC) for smoking cessation.

This description comes directly from the study's public registry record.

Talk to the study team

Research Coordinator  ·  509-638-2376  ·  wsu.appl@wsu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Washington State UniversitySpokane, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05181891